CAS RN 273404-37-8
CAS RN 273404-37-8
Tocris Bioscience™ VX 765
High affinity and selective caspase-4 and caspase 1/ICE inhibitor; orally bioavailable
VX-765, TRC
CAS: 273404-37-8 Formule moléculaire: C24 H33 Cl N4 O6 Poids moléculaire (g/mol): 509 Synonyme: L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-,N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide,Belnacasan,VX 765 Nom IUPAC: (2S)-1-[(2S)-2-[(4-amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide SMILES: CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)c3ccc(N)c(Cl)c3)C(C)(C)C
Belnacasan, MedChemExpress
MedChemExpress Belnacasan (VX-765) is an orally bioactive prodrug of VRT-043198, which is a potent and selective inhibitor of IL-converting enzyme (ICE)/caspase-1 with Kis of 0.8 nM and less than 0.6 nM for caspase-1 and caspase-4, respectively. Belnacasan (VX-765) inhibits the release of LPS-induced IL-1β and IL-18 by human PBMCs with an IC50 of ∼0.7 μM.